BD and UCL business reach exclusive license agreement to advance Development of new diagnostic tests for ovarian and breast cancers 11 Feb 2011 News
Pfizer, AstraZeneca, join UK GBP 5.6 M project on gene testing for personalised medicines Two major pharmaceutical companies are teaming up with the Cancer Research UK charity in a tumour genetics project 02 Feb 2011 News
UCL spin out sold to Amgen in $1 billion deal University College London cancer vaccines spin-out BioVex has been bought by US biotech company Amgen in deal worth up to $1 billion. 27 Jan 2011 News
Baylor College: Cell Medica signs exclusive license agreement with the Center for Cell and Gene Therapy 06 Jan 2011 News